BG Medicine Stock Price, News & Analysis (OTCMKTS:BGMD)

$0.07 0.00 (0.00 %)
(As of 01/23/2018 03:28 AM ET)
Previous Close$0.07
Today's Range$0.07 - $0.07
52-Week Range$0.02 - $0.12
Volume1,000 shs
Average Volume14,911 shs
Market Capitalization$740,000.00
P/E RatioN/A
Dividend YieldN/A
Beta1.79

About BG Medicine (OTCMKTS:BGMD)

BG Medicine logoBG Medicine, Inc. (BG Medicine) is a commercial-stage diagnostics company. The Company is engaged in commercializing diagnostic products that may be used to help guide the care and management of patients suffering from heart failure and related disorders. The Company's BGM Galectin-3 Test is an in vitro diagnostic device that employs a manual micro-titer platform to measure galectin-3 levels in blood plasma or serum for use as an aid in assessing the prognosis of chronic heart failure in conjunction with clinical evaluation. The automated galectin-3 tests are being developed and commercialized by its diagnostic instrument manufacturing partners and will be performed on its partners' automated platforms. The Company's CardioSCORE test is a multi-analyte biomarker-based blood test that was designed as an aid in the assessment of near-term risk for atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.

Receive BGMD News and Ratings via Email

Sign-up to receive the latest news and ratings for BGMD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Laboratories & Research
Sub-IndustryLife Sciences Tools & Services
SectorMedical
SymbolOTCMKTS:BGMD
CUSIP08861T10
Phone781-890-1199

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.57 million
Price / Sales0.47
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares11,370,000

BG Medicine (OTCMKTS:BGMD) Frequently Asked Questions

What is BG Medicine's stock symbol?

BG Medicine trades on the OTCMKTS under the ticker symbol "BGMD."

How were BG Medicine's earnings last quarter?

BG Medicine, Inc. (OTCMKTS:BGMD) released its quarterly earnings data on Tuesday, November, 17th. The medical research company reported ($0.27) earnings per share (EPS) for the quarter. The medical research company earned $334 million during the quarter, compared to analysts' expectations of $695 million. View BG Medicine's Earnings History.

Who are some of BG Medicine's key competitors?

Who are BG Medicine's key executives?

BG Medicine's management team includes the folowing people:

  • Harry W. Wilcox III, Chairman of the Board (Age 62)
  • Paul R. Sohmer M.D., President, Chief Executive Officer, Director (Age 67)
  • Stephen P. Hall, Chief Financial Officer, Executive Vice President, Treasurer (Age 65)
  • Aram Adourian Ph.D., Senior Vice President, Chief Scientific Officer (Age 46)
  • Jeffrey R. Luber J.D., Independent Director (Age 49)
  • James F. O'Connor CPA, Independent Director (Age 75)
  • Stelios B. Papadopoulos Ph.D., Independent Director (Age 68)

How do I buy BG Medicine stock?

Shares of BG Medicine can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is BG Medicine's stock price today?

One share of BG Medicine stock can currently be purchased for approximately $0.07.

How big of a company is BG Medicine?

BG Medicine has a market capitalization of $740,000.00 and generates $1.57 million in revenue each year.

How can I contact BG Medicine?

BG Medicine's mailing address is 303 Wyman Street Suite 300, Waltham MA, 02451. The medical research company can be reached via phone at 781-890-1199 or via email at [email protected]


MarketBeat Community Rating for BG Medicine (BGMD)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  53 (Vote Outperform)
Underperform Votes:  39 (Vote Underperform)
Total Votes:  92
MarketBeat's community ratings are surveys of what our community members think about BG Medicine and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

BG Medicine (OTCMKTS:BGMD) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

BG Medicine (OTCMKTS:BGMD) Earnings History and Estimates Chart

Earnings by Quarter for BG Medicine (OTCMKTS:BGMD)

BG Medicine (OTCMKTS BGMD) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/4/2016Q4 2015($0.08)ViewN/AView Earnings Details
11/17/2015Q315($0.27)$695.00 million$334.00 millionViewN/AView Earnings Details
8/14/2015Q2($0.23)$0.51 millionViewListenView Earnings Details
5/14/2015Q115($0.03)($0.04)$1.60 million$0.44 millionViewListenView Earnings Details
3/31/2015Q414($0.05)($0.04)$0.55 millionViewN/AView Earnings Details
11/13/2014Q3 2014($0.28)ViewN/AView Earnings Details
8/14/2014Q214($0.06)($0.06)$1.40 million$2.20 millionViewN/AView Earnings Details
5/14/2014Q114($0.08)($0.08)$1.30 million$0.74 millionViewN/AView Earnings Details
3/20/2014Q413($0.12)($0.06)$1.10 million$1.15 millionViewN/AView Earnings Details
11/6/2013Q3 2013($0.68)($0.52)ViewN/AView Earnings Details
8/8/2013Q2 2013($0.20)($0.18)$1.27 million$1.00 millionViewN/AView Earnings Details
5/9/2013Q1 2013($0.27)($0.21)$1.16 million$0.89 millionViewN/AView Earnings Details
3/13/2013Q4 2012($1.28)($0.56)ViewN/AView Earnings Details
11/13/2012Q312($0.33)($0.34)ViewN/AView Earnings Details
8/9/2012Q2 2012($1.40)($1.28)ViewN/AView Earnings Details
5/15/2012Q1 2012($1.24)($1.54)ViewN/AView Earnings Details
3/8/2012Q4 2011($1.12)($0.92)ViewN/AView Earnings Details
11/3/2011Q3 2011($1.32)($1.01)ViewN/AView Earnings Details
8/11/2011Q2 2011($1.20)($1.01)ViewN/AView Earnings Details
5/12/2011Q1 2011($1.40)($1.07)ViewN/AView Earnings Details
3/16/2011Q4 2010($4.72)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

BG Medicine (OTCMKTS:BGMD) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for BG Medicine (OTCMKTS:BGMD)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

BG Medicine (OTCMKTS BGMD) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 6.50%
Insider Trades by Quarter for BG Medicine (OTCMKTS:BGMD)

BG Medicine (OTCMKTS BGMD) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/9/2015Noubar AfeyanDirectorSell46,438$0.56$26,005.28View SEC Filing  
12/11/2014Edwin M Kania JrMajor ShareholderSell634,390$0.32$203,004.80View SEC Filing  
1/30/2013Stelios PapadopoulosDirectorBuy250,000$2.00$500,000.00View SEC Filing  
11/19/2012Brian S PosnerDirectorBuy10,000$1.17$11,700.00View SEC Filing  
11/15/2012Stephane BancelChairmanBuy100,000$1.26$126,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

BG Medicine (OTCMKTS BGMD) News Headlines

Source:
DateHeadline
Critical Analysis: BG Medicine (BGMD) vs. BioTelemetry (BEAT)Critical Analysis: BG Medicine (BGMD) vs. BioTelemetry (BEAT)
www.americanbankingnews.com - December 5 at 7:28 PM
Head to Head Analysis: BioTelemetry (BEAT) versus BG Medicine (BGMD)Head to Head Analysis: BioTelemetry (BEAT) versus BG Medicine (BGMD)
www.americanbankingnews.com - December 4 at 3:18 PM
Head-To-Head Analysis: BioTelemetry (BEAT) & BG Medicine (BGMD)Head-To-Head Analysis: BioTelemetry (BEAT) & BG Medicine (BGMD)
www.americanbankingnews.com - December 1 at 5:40 PM
Signal Genetics (MGEN) and BG Medicine (BGMD) Financial ContrastSignal Genetics (MGEN) and BG Medicine (BGMD) Financial Contrast
www.americanbankingnews.com - November 25 at 9:26 AM
BG Medicine (BGMD) and BioTelemetry (BEAT) Critical ComparisonBG Medicine (BGMD) and BioTelemetry (BEAT) Critical Comparison
www.americanbankingnews.com - November 17 at 9:30 PM

SEC Filings

BG Medicine (OTCMKTS:BGMD) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

BG Medicine (OTCMKTS:BGMD) Income Statement, Balance Sheet and Cash Flow Statement

Chart

BG Medicine (OTCMKTS BGMD) Stock Chart for Tuesday, January, 23, 2018

Loading chart…

This page was last updated on 1/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.